HPV-RELATED SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be just as effective for HPV throat cancer?
Disease control Recruiting nowThis study tests whether a personalized, lower dose of radiation, combined with standard chemotherapy, works as well as the standard radiation dose for people with HPV-positive throat cancer. About 291 participants will be randomly assigned to either the lower-dose or standard-do…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers (cervical, throat, anal, and others). Participants receive specially engineered immune cells designed to attack HPV-infected tumor cells, along with chemotherapy and a drug to boost cell activity. T…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Immune cells take aim at HPV tumors before standard therapy
Disease control Recruiting nowThis study tests whether giving a single dose of specially engineered immune cells (E7 TCR-T cells) before standard treatment (chemoradiation or surgery) can shrink or eliminate tumors in people with advanced HPV-related cancers. About 15 participants will have their own T cells …
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a shorter, gentler treatment beat HPV cancer? new study aims to find out
Disease control Recruiting nowThis study tests whether giving immunotherapy (with or without chemo) before standard treatments can allow doctors to use less intense, gentler therapy while still curing the cancer. About 32 adults with advanced HPV-related head and neck cancer will receive the drugs first, then…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 08, 2026 12:02 UTC